Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sheba Medical Center |
---|---|
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00619437 |
Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were shown to characterize the families of patients with schizophrenia. This is probably due to the high genetic heterogenity of this illness. Thus, it is important to investigate the genetic factor in relatively genetically homogenous populations. Many studies have indicate that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish ancestry with multiplex schizophrenia.
Condition |
---|
Schizophrenia |
Study Type: | Observational |
Study Design: | Family-Based, Prospective |
Official Title: | Genetics of Schizophrenia |
Ages Eligible for Study: | 18 Years to 78 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
schizophrenia
Inclusion Criteria:
Exclusion Criteria:
Contact: Raz Gross, MD, MPH | 972 3 530 3962 | razg@gertner.health.gov.il |
Israel | |
Sheba Medical Center | |
Tel Hashomer, Israel |
Study Director: | Michael Bunzel, MD | Psychiatric ward, Sheba Medical Center |
Responsible Party: | Mental Health Epidemiology, The Gertner Institute for Epidemiology ( Raz Gross, Head ) |
Study ID Numbers: | SHEBA-07-4620-RG-CTIL |
Study First Received: | February 10, 2008 |
Last Updated: | February 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00619437 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
schizophrenia genetics family multiplex haplotypes |
Schizophrenia Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |